A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

NCT00157872 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MK0966; rofecoxib
DRUG: Comparator: naproxen tablet 500 mg

Sponsor

Merck Sharp & Dohme LLC